Advertisement
Advertisement

TNDM

TNDM logo

Tandem Diabetes Care, Inc.

20.56
USD
Sponsored
-0.72
-3.38%
Sep 02, 16:00 UTC -4
Closed
exchange

After-Market

20.62

+0.06
+0.30%

TNDM Earnings Reports

Positive Surprise Ratio

TNDM beat 23 of 43 last estimates.

53%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$271.44M
/
-$0.23
Implied change from Q2 26 (Revenue/ EPS)
+6.63%
/
-25.81%
Implied change from Q3 25 (Revenue/ EPS)
+8.90%
/
-25.81%

Tandem Diabetes Care, Inc. earnings per share and revenue

On Aug 06, 2026, TNDM reported earnings of -0.31 USD per share (EPS) for Q2 26, beating the estimate of -0.32 USD, resulting in a 4.94% surprise. Revenue reached 254.56 million, compared to an expected 260.08 million, with a -2.12% difference. The market reacted with a +19.11% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.23 USD, with revenue projected to reach 271.44 million USD, implying an decrease of -25.81% EPS, and increase of 6.63% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Electromed, Inc.
Report Date
Aug 25, 2026 For Q4 26
Estimate
$0.31
Actual
$0.39
Surprise
+23.34%
logo
Accuray Incorporated
Report Date
Aug 19, 2026 For Q4 26
Estimate
-$0.10
Actual
$0.00
Surprise
+103.92%
FAQ
For Q2 2026, Tandem Diabetes Care, Inc. reported EPS of -$0.31, beating estimates by 4.94%, and revenue of $254.56M, -2.12% below expectations.
The stock price moved up 19.11%, changed from $18.79 before the earnings release to $22.38 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on -- analysts, Tandem Diabetes Care, Inc. is expected to report EPS of -$0.23 and revenue of $271.44M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement